Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Non Operating Income: 2020-2024

Historic Non Operating Income for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to $6.6 million.

  • Prime Medicine's Non Operating Income rose 97.84% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 5.88%. This contributed to the annual value of $6.6 million for FY2024, which is 3.21% up from last year.
  • Per Prime Medicine's latest filing, its Non Operating Income stood at $6.6 million for FY2024, which was up 3.21% from $6.4 million recorded in FY2023.
  • Prime Medicine's 5-year Non Operating Income high stood at $6.6 million for FY2024, and its period low was -$81.4 million during FY2021.
  • Over the past 3 years, Prime Medicine's median Non Operating Income value was $6.4 million (recorded in 2023), while the average stood at $2.2 million.
  • In the last 5 years, Prime Medicine's Non Operating Income plummeted by 13,218.99% in 2021 and then spiked by 202.49% in 2023.
  • Over the past 5 years, Prime Medicine's Non Operating Income (Yearly) stood at -$611,000 in 2020, then tumbled by 13,218.99% to -$81.4 million in 2021, then skyrocketed by 92.35% to -$6.2 million in 2022, then soared by 202.49% to $6.4 million in 2023, then climbed by 3.21% to $6.6 million in 2024.